Trek Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,245
Closed -$204K 513
2026
Q1
$204K Buy
3,245
+71
+2% +$5.68K 0.01% 458
2025
Q4
$303K Sell
3,174
-38,145
-92% -$3.74M 0.02% 366
2025
Q3
$4.03M Buy
41,319
+7,934
+24% +$822K 0.24% 109
2025
Q2
$3.59M Sell
33,385
-1,119
-3% -$113K 0.24% 109
2025
Q1
$3.48M Buy
34,504
+31,339
+990% +$3.16M 0.25% 95
2024
Q4
$283K Sell
3,165
-41,966
-93% -$3.69M 0.02% 340
2024
Q3
$3.78M Sell
45,131
-2,928
-6% -$231K 0.28% 95
2024
Q2
$3.7M Sell
48,059
-2,104
-4% -$154K 0.29% 86
2024
Q1
$3.44M Buy
+50,163
New +$3.23M 0.27% 97

Other funds holding BSX

Trek Financial's BSX Position: Q2 2026 in Review

Trek Financial sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,245 shares — an estimated $204K sold.

Trek Financial first reported a position in BSX in Q1 2024 and held it in 9 quarters. The position peaked at $4.03M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Trek Financial reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Trek Financial sold 3,245 Boston Scientific shares in Q2 2026, an estimated $204K.
  • Trek Financial first reported a position in Boston Scientific in Q1 2024 and held it in 9 quarters.
  • Trek Financial's Boston Scientific position peaked at $4.03M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.